REFERENCES
1. Public organization «Russian Association of Endocrinologists» type 2 diabetes mellitus in adults. Moscow, 2019: 229 p. (in Russian)
2. WHO. Diabetes. Basic facts. 2020. URL: https://www.who.int/ru/news-room/fact-sheets/detail/diabetes
3. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care. 2003; 26 (suppl 1): S 5-20. DOI: https://doi.org/10.2337/diacare.26.2007.s5
4. Ewald N., Kaufmann C., Raspe A., Kloer H.U., Bretzel R.G., Hardt P.D. Prevalence of diabetes mellitus secondary to pancreatic diseases (type 3c). Diabetes Metab Res Rev. 2012; 28 (4): 338-42. DOI: https://doi.org/10.1002/dmrr.2260
5. Moran A., Dunitz J., Nathan B., Saeed A., Holme B., Thomas W. Cystic fibrosis-related diabetes: current trends in prevalence, incidence, and mortality. Diabetes Care. 2009; 32 (9): 1626-31. DOI: https://doi.org/10.2337/dc09-0586
6. Aslam M., Vijayasarathy K., Talukdar R., Sasikala M., Nageshwar Reddy D. Reduced pancreatic polypeptide response is associated with early alteration of glycemic control in chronic pancreatitis. Diabetes Res Clin Pract. 2020; 160: 107993. DOI: https://doi.org/10.1016/j.dia-bres.2019.107993
7. Pezzilli R. Etiology of chronic pancreatitis: has it changed in the last decade? World J Gastroenterol. 2009; 15 (38): 4737-40. DOI: https://doi.org/10.3748/wjg.15.4737
8. Hardt P., Kloer H., Brendel M., Bretzel R. Is pancreatic (type 3c) diabetes underdiagnosed and misdiagnosed? Diabetes Care. 2008; 31 (suppl 2): S 165-9.
9. Ewald N., Raspe A., Kaufmann C., Bretzel R., Kloer H., Hardt P. Determinants of exocrine pancreatic function as measured by fecal elastase 1 concentrations (FEC) in patients with diabetes mellitus. Eur J Med Res. 2009; 14: 118-22.
10. Ministry of Health of the Russian, Federation Public Association «Russian Association of Endocrinologists», Federal State Budgetary Institution «National Medical Research Center of Endocrinology». Algorithms of specialized medical care for patients with diabetes mellitus. Moscow, 2019: 214 p. (in Russian)
11. Ewald N., Hardt P.D. Diagnosis and treatment of diabetes mellitus in chronic pancreatitis. World J Gastroenterol. 2013; 19 (42): 7276-81. DOI: https://doi.org/10.3748/wjg.v19.i42.7276
12. Zuvarox T., Belletieri C. Malabsorption Syndromes. In StatPearls. Treasure Island, FL: StatPearls Publishing, 2021.
13. Ewald N., Bretzel R.G. Diabetes mellitus secondary to pancreatic diseases (type 3c) - are we neglecting an important disease? Eur J Intern Med. 2013; 24 (3): 203-6. DOI: https://doi.org/10.1016/j.ejim.2012.12.017
14. Klapdor S., Richter E., Klapdor R. Vitamin D status and peroral vitamin D supplementation in patients suffering from chronic pancreatitis and pancreatic cancer disease. Anticancer Res. 2012; 32 (5): 1991-8.
15. Tolhurst G., Reimann F., Gribble F.M. Nutritional regulation of glucagon-like peptide-1 secretion. J Physiol. 2009; 587 (1): 27-32. DOI: https://doi.org/10.1113/jphysiol.2008.164012
16. Saisho Y. Incretin-based therapy and pancreatitis: accumulating evidence and unresolved questions. Ann Transl Med. 2018; 6 (7): 131. DOI: https://doi.org/10.21037/atm.2018.02.24
17. Knop F.K. Incretin hormones and beta cell function in chronic pancreatitis. Dan Med Bull. 2010; 57 (7): B 4163.
18. Mumme L., Breuer T.G.K., Rohrer S., Schenker N., Menge B.A., Holst J.J., et al. Defects in α-cell function in patients with diabetes due to chronic pancreatitis compared with patients with type 2 diabetes and healthy individuals. Diabetes Care. 2017; 40 (10): 1314-22. DOI: https://doi.org/10.2337/dc17-0792
19. Lundberg R., Beilman G.J., Dunn T.B., Pruett T.L., Freeman M.L., Ptacek P.E., et al. Early alterations in glycemic control and pancreatic endocrine function in nondiabetic patients with chronic pancreatitis. Pancreas. 2016; 45 (4): 565-71. DOI: https://doi.org/10.1097/mpa.0000000000000491